Piedmont Investment Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Piedmont Investment Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,827	Closed	-$230K	–	741
2020 Q1	$230K	Buy	5,827 +92	+2%	+$5.38K	0.01%	690
2019 Q4	$341K	Sell	5,735 -836	-13%	-$44.9K	0.01%	691
2019 Q3	$350K	Sell	6,571 -1,277	-16%	-$65.5K	0.01%	683
2019 Q2	$401K	Buy	+7,848	New	+$365K	0.02%	642
2018 Q3	–	Sell	-972	Closed	-$46K	–	2472
2018 Q2	$46K	Buy	+972	New	+$40.2K	﹤0.01%	1322

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Piedmont Investment Advisors's SYNH Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2020, closing a stake of 5,827 shares — an estimated $230K sold.

Piedmont Investment Advisors first reported a position in SYNH in Q2 2018 and held it in 5 quarters. The position peaked at $401K in Q2 2019. 285 funds tracked by Wall St. Rank hold SYNH as of Q2 2020.

Piedmont Investment Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2020 after selling out during the quarter.
Piedmont Investment Advisors sold 5,827 Syneos Health, Inc. Class A Common Stock shares in Q2 2020, an estimated $230K.
Piedmont Investment Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2018 and held it in 5 quarters.
Piedmont Investment Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $401K in Q2 2019.
285 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.